Kratos Defense (NASDAQ:KTOS) Posts 30.5% Revenue Growth in Q2 but GAAP Operating Loss Widens on Heavy Investment

Kratos Defense & Security Solutions (NASDAQ: KTOS) reported Q2 2026 revenue of $458.8 million, up 30.5% year over year from $351.5 million, but a GAAP operating loss of $1.6 million underscored the weight of accelerated investment spending in the quarter. Despite the operating loss, adjusted EPS of $0.21 beat Wall Street's consensus by 44.4%, and full-year revenue guidance was raised. Shares gained 5.41% on Tuesday, August 4, while the S&P 500 rose 1.80%.

Q2 2026 Results

• Revenue: $458.8 million, up 30.5% year over year and 19.1% on an organic basis, versus $351.5 million in Q2 2025.
• GAAP net income: $4.4 million ($0.02 per share), compared to $2.9 million ($0.02 per share) in Q2 2025.
• Adjusted EPS: $0.21, up 90.9% from $0.11 in Q2 2025.
• Adjusted EBITDA: $38.2 million for the quarter.
• Bookings and backlog: Consolidated bookings of $492.2 million yielded a book-to-bill ratio of 1.1 to 1.0 for the quarter; the trailing twelve-month book-to-bill ratio was 1.3 to 1.0 on bookings of $1.990 billion. Total consolidated backlog reached $2.084 billion as of June 28, 2026.

What Drove the Results

Adjusted EPS of $0.21 exceeded the analyst consensus by 44.4%, and revenue of $458.8 million cleared Wall Street's expectations. The GAAP operating line, however, swung to a loss of $1.6 million, driven by $16.3 million in non-cash stock compensation, $13.6 million in company-funded research and development, and $12.5 million in non-cash amortization, alongside deliberate spending on staffing, inventory, and production capacity ramp-up.

Free cash flow used in operations was $18.9 million after $17.2 million in capital expenditures and net of $9.3 million received from the sale of company-owned Valkyrie unmanned aircraft. Operating cash outflow of $11.0 million reflected working capital pressure from the 30.5% revenue increase, which expanded receivables balances, combined with inventory builds tied to production scale-up.

The Kratos Government Solutions segment generated $379.7 million in revenue, up 36.4% year over year and 22.0% organically, with particularly sharp organic growth in Defense Rocket Systems (50.2%), Turbine Technologies (43.3%), and Microwave Products (29.5%). The Unmanned Systems segment contributed $79.1 million, up 8.1% organically from $73.2 million, with growth primarily from Valkyrie-related activity. KGS adjusted EBITDA rose to $33.1 million from $24.7 million in Q2 2025.

CEO Eric DeMarco noted that Kratos' strategy of making internally funded investments to bring relevant hardware and software to market, engineered for affordable mass production at scale, aligns with the Department of Defense's priorities, and that business momentum is expected to accelerate in the second half of 2026 and into 2027. The company's bid and proposal pipeline expanded to $15.0 billion as of June 28, 2026, from $14.3 billion at the end of Q1 2026.

Wall Street View

Cantor Fitzgerald analyst Colin Canfield maintained an Overweight rating on Kratos following the results but lowered his price target to $100 from $115, per a Benzinga report. The company's full-year 2026 revenue guidance was raised to $1.750 billion to $1.810 billion, implying organic revenue growth of approximately 18% to 23% versus full year 2025. Q3 2026 organic growth is forecast at approximately 19% to 25%, with Q4 2026 organic growth projected at approximately 19% to 31%. The Unmanned Systems segment is now expected to deliver approximately 10% organic growth for the full year, reflecting recent contract awards including Valkyrie.

Investor Takeaway

The Q2 results highlight a company deliberately trading near-term profitability for capacity and pipeline expansion: GAAP operating income was negative while adjusted EPS nearly doubled year over year. Investors evaluating KTOS should weigh the $15.0 billion bid pipeline and a 1.3 to 1.0 trailing twelve-month book-to-bill ratio as forward demand indicators against the reality that elevated investment spending, including R&D, capital expenditures, and staffing costs, is explicitly expected to persist at least through fiscal year 2027.